Ceza Formulations Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 1999.
1999 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Ceza Formulations Private Limited

Ceza Formulations Private Limited, a active private limited company, was established on 26 March 1999 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1999PTC013421. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.

It upholds a compliant status. Employing 8 professional, Its leadership includes Narendra Kumar Dalawat (Director), Mimoh Paliwal (Director), Krishnakant Mundra (Director). Past directors included Naveen Khaitan, Narendra Kumar Dalawat, Mimoh Paliwal. It holds ₹7.80 M open charges and ₹1.03 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 236,Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP1999PTC013421

  • Registration Number

    013421

  • Incorporation Date

    26 March 1999

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 26 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.80 M
  • Satisfied Charges ₹ 1.03 Cr
  • Revenue Growth **** 58.59%
  • Profit Growth **** 14.48%
  • Ebitda **** 3.58%
  • Net Worth -38.90%
  • Total Assets -4.27%
Company report

Ceza Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ceza Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ceza Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Narendra Kumar Dalawat Director 11 Jul 2016 Current
Mimoh Paliwal Director 10 Nov 2014 Current
Krishnakant Mundra Director 10 Nov 2014 Current
Anil Kumar Vyas Director 13 Dec 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Nov 2011 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Additional Director 27 Sep 2015 Past
Pramod Abcsdd Additional Director 27 Sep 2015 Past
Pramod Abcsdd Director 18 Aug 2016 Past
Pramod Abcsdd Additional Director 27 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ceza Formulations.

Ceza Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.59% increase. The company also saw a substantial improvement in profitability, with a 14.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.9%.

Ceza Formulations revenue growth over time
Ceza Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 58.59%
*******
*******
*******
*******
Revenue from Operations
*******
 58.62%
*******
*******
*******
*******
Total Assets
*******
 -4.27%
*******
*******
*******
*******
Profit or Loss
*******
 14.48%
*******
*******
*******
*******
Net Worth
*******
 -38.90%
*******
*******
*******
*******
EBITDA
*******
 3.58%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ceza Formulations?

Unlock access to Ceza Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,800,000.00

Satisfied Charges

₹10,250,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.78 Cr
Latest Charge Details
Date Lender Amount Status
17 Dec 2018 Others ₹7.80 M Open
24 Oct 2016 Others ₹9.25 M Satisfied
25 Apr 2001 State Bank Of India ₹0.50 M Satisfied
25 Apr 2001 State Bank Of Indore ₹0.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ceza Formulations?

Ceza Formulations has a workforce of 8 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ceza Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ceza Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ceza Formulations
Recent Activity within the Organization
  • Annual General Meeting

    Ceza Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Ceza Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Charges

    A charge with Others of Rs. 7.80 M registered on 17 Dec 2018 with Charge ID 100234068 was modified on 06 Mar 2019. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 24 Oct 2016 via Charge ID 100060752 with Others was fully satisfied on 05 Feb 2019. was documented.

  • Charges

    A charge with Others amounted to Rs. 7.80 M with Charge ID 100234068 was registered on 17 Dec 2018. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 9.25 M with Charge ID 100060752 was registered on 24 Oct 2016. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ceza Formulations Private Limited?

The CIN of Ceza Formulations Private Limited is U24232MP1999PTC013421.

Where is Ceza Formulations Private Limited headquartered?

Ceza Formulations Private Limited is headquartered at 236,Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452001.

When was Ceza Formulations Private Limited incorporated?

Ceza Formulations Private Limited was incorporated on 26 March 1999.

Who are the current directors of Ceza Formulations Private Limited?

The current directors of Ceza Formulations Private Limited are

What is the primary industry of Ceza Formulations Private Limited?

The primary industry of Ceza Formulations Private Limited is Manufacturing.

Is Ceza Formulations Private Limited a listed company?

Ceza Formulations Private Limited is unlisted.

What is the capital structure of Ceza Formulations Private Limited?

The authorized capital of Ceza Formulations Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.

What is the compliance status of Ceza Formulations Private Limited?

The compliance status of Ceza Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available